secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001493152-23-014937
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioAffinity appoints Michael Dougherty as CFO; former CFO Edwards resigns
-------------------------------------------------------------------------

- Michael Edwards resigned as CFO effective May 1; will serve as consultant for transition.
- Michael Dougherty appointed CFO; previously CFO of Alexa Business Domains at Amazon.
- Dougherty receives $250K base salary, $30K cash signing bonus, plus $100K restricted stock grant.
- Dougherty brings 20+ years finance experience; will support commercial rollout of CyPath® Lung.
- Company is a biotech focused on noninvasive early-stage cancer detection.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315223014937/0001493152-23-014937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315223014937/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-014937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer